- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-mer
- Ligands
- 12 x NAG- FUC: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 24 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.2: 1 residues within 4Å:- Chain A: N.125
No protein-ligand interaction detected (PLIP)NAG-NAG.3: 4 residues within 4Å:- Chain A: P.103, T.104, N.121, Y.138
No protein-ligand interaction detected (PLIP)NAG-NAG.5: 3 residues within 4Å:- Chain A: N.344, S.346
- Ligands: NAG-NAG.10
No protein-ligand interaction detected (PLIP)NAG-NAG.6: 5 residues within 4Å:- Chain A: N.200, I.238, D.239, P.240, I.312
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:I.312
NAG-NAG.7: 3 residues within 4Å:- Chain A: E.52, N.193, N.205
No protein-ligand interaction detected (PLIP)NAG-NAG.10: 6 residues within 4Å:- Chain A: E.347, N.350, T.352, K.353, K.356
- Ligands: NAG-NAG.5
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:K.353
NAG-NAG.11: 6 residues within 4Å:- Chain A: N.294, T.296, Q.297, E.358, N.359, M.360
No protein-ligand interaction detected (PLIP)NAG-NAG.12: 4 residues within 4Å:- Chain A: N.226, P.252, N.395
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN.8
No protein-ligand interaction detected (PLIP)NAG-NAG.16: 1 residues within 4Å:- Chain C: N.125
No protein-ligand interaction detected (PLIP)NAG-NAG.17: 4 residues within 4Å:- Chain C: P.103, T.104, N.121, Y.138
No protein-ligand interaction detected (PLIP)NAG-NAG.19: 3 residues within 4Å:- Chain C: N.344, S.346
- Ligands: NAG-NAG.24
No protein-ligand interaction detected (PLIP)NAG-NAG.20: 5 residues within 4Å:- Chain C: N.200, I.238, D.239, P.240, I.312
1 PLIP interactions:1 interactions with chain C- Hydrophobic interactions: C:I.312
NAG-NAG.21: 3 residues within 4Å:- Chain C: E.52, N.193, N.205
No protein-ligand interaction detected (PLIP)NAG-NAG.24: 6 residues within 4Å:- Chain C: E.347, N.350, T.352, K.353, K.356
- Ligands: NAG-NAG.19
1 PLIP interactions:1 interactions with chain C- Hydrophobic interactions: C:K.353
NAG-NAG.25: 6 residues within 4Å:- Chain C: N.294, T.296, Q.297, E.358, N.359, M.360
No protein-ligand interaction detected (PLIP)NAG-NAG.26: 4 residues within 4Å:- Chain C: N.226, P.252, N.395
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN.22
No protein-ligand interaction detected (PLIP)NAG-NAG.30: 1 residues within 4Å:- Chain E: N.125
No protein-ligand interaction detected (PLIP)NAG-NAG.31: 4 residues within 4Å:- Chain E: P.103, T.104, N.121, Y.138
No protein-ligand interaction detected (PLIP)NAG-NAG.33: 3 residues within 4Å:- Chain E: N.344, S.346
- Ligands: NAG-NAG.38
No protein-ligand interaction detected (PLIP)NAG-NAG.34: 5 residues within 4Å:- Chain E: N.200, I.238, D.239, P.240, I.312
1 PLIP interactions:1 interactions with chain E- Hydrophobic interactions: E:I.312
NAG-NAG.35: 3 residues within 4Å:- Chain E: E.52, N.193, N.205
No protein-ligand interaction detected (PLIP)NAG-NAG.38: 6 residues within 4Å:- Chain E: E.347, N.350, T.352, K.353, K.356
- Ligands: NAG-NAG.33
1 PLIP interactions:1 interactions with chain E- Hydrophobic interactions: E:K.353
NAG-NAG.39: 6 residues within 4Å:- Chain E: N.294, T.296, Q.297, E.358, N.359, M.360
No protein-ligand interaction detected (PLIP)NAG-NAG.40: 4 residues within 4Å:- Chain E: N.226, P.252, N.395
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN.36
No protein-ligand interaction detected (PLIP)- 3 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-FUC.4: 5 residues within 4Å:- Chain A: T.147, A.148, I.149, R.156, N.161
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:A.148
- Hydrophobic interactions: A:T.147
NAG-NAG-FUC.18: 5 residues within 4Å:- Chain C: T.147, A.148, I.149, R.156, N.161
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:A.148
- Hydrophobic interactions: C:T.147
NAG-NAG-FUC.32: 5 residues within 4Å:- Chain E: T.147, A.148, I.149, R.156, N.161
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:A.148
- Hydrophobic interactions: E:T.147
- 3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN-MAN-MAN.8: 13 residues within 4Å:- Chain A: Y.30, H.35, N.36, P.176, V.218, L.225, N.226, N.335, C.336, R.387, T.393, S.394
- Ligands: NAG-NAG.12
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:C.336
NAG-NAG-BMA-MAN-MAN-MAN-MAN.22: 13 residues within 4Å:- Chain C: Y.30, H.35, N.36, P.176, V.218, L.225, N.226, N.335, C.336, R.387, T.393, S.394
- Ligands: NAG-NAG.26
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:C.336
NAG-NAG-BMA-MAN-MAN-MAN-MAN.36: 13 residues within 4Å:- Chain E: Y.30, H.35, N.36, P.176, V.218, L.225, N.226, N.335, C.336, R.387, T.393, S.394
- Ligands: NAG-NAG.40
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:C.336
- 24 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.43: 1 residues within 4Å:- Chain A: N.152
Ligand excluded by PLIPNAG.44: 3 residues within 4Å:- Chain A: I.195, N.232, Q.233
Ligand excluded by PLIPNAG.45: 2 residues within 4Å:- Chain A: N.262, G.284
Ligand excluded by PLIPNAG.46: 1 residues within 4Å:- Chain A: N.303
Ligand excluded by PLIPNAG.47: 4 residues within 4Å:- Chain A: R.314, N.316, Q.416
- Ligands: NAG.49
Ligand excluded by PLIPNAG.48: 3 residues within 4Å:- Chain A: R.287, N.389, I.390
Ligand excluded by PLIPNAG.49: 4 residues within 4Å:- Chain A: E.412, Q.416, N.417
- Ligands: NAG.47
Ligand excluded by PLIPNAG.50: 2 residues within 4Å:- Chain B: V.108, N.112
Ligand excluded by PLIPNAG.51: 1 residues within 4Å:- Chain C: N.152
Ligand excluded by PLIPNAG.52: 3 residues within 4Å:- Chain C: I.195, N.232, Q.233
Ligand excluded by PLIPNAG.53: 2 residues within 4Å:- Chain C: N.262, G.284
Ligand excluded by PLIPNAG.54: 1 residues within 4Å:- Chain C: N.303
Ligand excluded by PLIPNAG.55: 4 residues within 4Å:- Chain C: R.314, N.316, Q.416
- Ligands: NAG.57
Ligand excluded by PLIPNAG.56: 3 residues within 4Å:- Chain C: R.287, N.389, I.390
Ligand excluded by PLIPNAG.57: 4 residues within 4Å:- Chain C: E.412, Q.416, N.417
- Ligands: NAG.55
Ligand excluded by PLIPNAG.58: 2 residues within 4Å:- Chain D: V.108, N.112
Ligand excluded by PLIPNAG.59: 1 residues within 4Å:- Chain E: N.152
Ligand excluded by PLIPNAG.60: 3 residues within 4Å:- Chain E: I.195, N.232, Q.233
Ligand excluded by PLIPNAG.61: 2 residues within 4Å:- Chain E: N.262, G.284
Ligand excluded by PLIPNAG.62: 1 residues within 4Å:- Chain E: N.303
Ligand excluded by PLIPNAG.63: 4 residues within 4Å:- Chain E: R.314, N.316, Q.416
- Ligands: NAG.65
Ligand excluded by PLIPNAG.64: 3 residues within 4Å:- Chain E: R.287, N.389, I.390
Ligand excluded by PLIPNAG.65: 4 residues within 4Å:- Chain E: E.412, Q.416, N.417
- Ligands: NAG.63
Ligand excluded by PLIPNAG.66: 2 residues within 4Å:- Chain F: V.108, N.112
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Andrabi, R. et al., The Chimpanzee SIV Envelope Trimer: Structure and Deployment as an HIV Vaccine Template. Cell Rep (2019)
- Release Date
- 2019-06-05
- Peptides
- Envelope glycoprotein gp160: ACE
Envelope glycoprotein gp160: BDF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
CE
DB
BD
EF
F
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-mer
- Ligands
- 12 x NAG- FUC: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 24 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 24 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Andrabi, R. et al., The Chimpanzee SIV Envelope Trimer: Structure and Deployment as an HIV Vaccine Template. Cell Rep (2019)
- Release Date
- 2019-06-05
- Peptides
- Envelope glycoprotein gp160: ACE
Envelope glycoprotein gp160: BDF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
CE
DB
BD
EF
F